Machine Learning

Despite a guilty plea, a new book by a former FBI agent claims the Idaho Murders case is far from closed, citing flaws in DNA and police work.

After seven years in stealth, Madrid-based Xoople emerges with unicorn status to commercialize a satellite data platform for the coming agentic AI era.

Decoy Therapeutics touts a revolutionary AI platform for multi-virus drugs, but faces financial hurdles. An upcoming investor event could define its future.

A Charlotte dentist’s late-night parenting struggle sparks a patented invention, disrupting a beloved childhood tradition and making her a national innovator.

Enlyte's acquisition of PartsTrader signals a major shift in the auto claims industry, promising more efficiency but raising questions about competition.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

Metazoa's new Intelligent Assistant for Salesforce goes beyond diagnostics, promising to actively help admins and developers remediate org complexity.

A long-acting ketamine injection shows promise in treating severe depression without the harsh side effects and monitoring, potentially expanding access for millions.

New preclinical data for ATNM-400 and Actimab-A shows promise for treating resistant solid tumors and AML, highlighting a new frontier in cancer therapy.

A key summit will dissect Vietnam's plan to navigate US tariffs and Mideast conflict while pursuing its ambitious goal of becoming a high-income nation.

A new service brings quiet, eco-friendly robotic lawnmowers to Toronto and Hamilton, promising to save homeowners time, money, and weekend headaches.

A new grant from entrepreneur Andrew Hillman seeks global talent to solve biotech's biggest challenges. Who is the man behind this ambitious mission?

A new analysis finds 73% of B2B buyers use AI tools, which convert 5x better than Google. Yet, 78% of marketers have no strategy for this new reality.

Finnish defense firm Sensofusion buys aircraft maker Atol Aviation, shifting counter-drone warfare from the ground to the sky in a major strategic leap.

As AI code floods development, CloudBees launches Smart Tests to slash test times, cut costs, and restore control to overwhelmed CI/CD pipelines.

A new partnership aims to tackle the US energy crisis by delivering mobile natural gas to power-hungry data centers and industries the grid can't support.

As Corebridge Financial prepares to report Q1 results on May 4, investors are watching to see if its 2025 momentum can weather new industry challenges.

As the Final Four tips off, AI firm TISC hires NCAA champion 'Scooter' Barry to bridge the gap between high-tech analytics and coaching intuition.